Fluocinonide Topical (Lidex)
Jump to navigation
Jump to search
Indications
- relief of inflammatory dermatoses (dermatitis)
- alleriges
- cutaneous T-cell lymphoma[4]
Dosage
Topical:
cream/ointment/solution/gel 0.05%.
cream/ointment/gel(15 g, 30 g, 60 g)
High potency (0.05%).
Adverse effects
- uncommon (< 1%)
- burning, itching, skin irritation, dryness, folliculitis, hypertrichosis, acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infection, skin atrophy, striae, miliaria, intracranial hypertension, hypothalamic-pituitary-adrenal axis suppression, Cushing's syndrome, growth retardation
- drug adverse effects of glucocorticoids
- drug adverse effects of topical glucocorticoids
- drug adverse effects of immunosuppressive agents
Mechanism of action
- anti-inflammatory high-potency topical glucocorticoid (class 2)[4]
More general terms
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- ↑ Kaiser Permanente Northern California Regional Drug Formulary, 1998
- ↑ Jump up to: 4.0 4.1 4.2 4.3 Deprecated Reference1) Medical Knowledge Self Assessment Program (MKSAP) 17, American College of Physicians, Philadelphia 2015